Development of a Decision-making Aid for Referring Severe Kidney Injury Patients for Nephrology Consultations
IRA Cible
1 other identifier
observational
319
1 country
1
Brief Summary
Acute kidney injury is a frequent and growing complication associated with a risk of progressing into a chronic kidney disease. Recent guidelines have recommended systematic consultations with a nephrologist 3-6 months following hospitalization. Risk factors of developing chronic kidney disease between hospital visits are understudied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2016
CompletedFirst Submitted
Initial submission to the registry
June 16, 2017
CompletedFirst Posted
Study publicly available on registry
June 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedNovember 17, 2025
November 1, 2025
1.4 years
June 16, 2017
November 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Develop a prognostic score of progression to chronic kidney disease at 6 months in patients requiring hospitalization for dialysis for acute kidney injury to identify those who would benefit from consultation with a nephrologist
6 months
Secondary Outcomes (5)
Identify new risk factors for progression to chronic kidney disease at 6 months post dialysis for acute kidney injury pre-hospitalization and during hospitalization and day of discharge
6 months
Identify renal phenotype of patients with chronic kidney disease
6 months
Evaluate mortality during hospital stay
1 months
Evaluate mortality at medium-term
6 months
Identify specific therapeutic interventions put into place during the 6 month consultation
6 months
Study Arms (1)
Patients with acute kidney injury
Requiring treatment with dialysis
Interventions
Collect clinical information and assess risk factors
Eligibility Criteria
Patients undergoing dialysis for acute kidney injury. All new adults (\>18 years old) hospitalized in a university center with severe AKI was included from August 2016 to December 2017. Inclusion criteria was a severe AKI defined by dialysis start for AKI or an increase of Scr upper 354 μmol/L. Exclusion criteria was CKD stage 5 , patients living with kidney transplant, plan dialysis for bilateral surgery nephrectomy, patient witch justice protection and refuse to participate. Eligible patients were identified by physicians for ICU and nephrology department and by laboratory biochemistry department for others wards. A Biochemistry alert system controlled the exhaustively of inclusion in ICU and Nephrology department during the period of the study.
You may qualify if:
- Age \>18 years
- Suffering from acute kidney injury treated with dialysis
- hospitalized in a university center from August 2016 to December 2017 with severe AKI defined according to 2 of the 3 criterion definitions of KDIGO stage AKI: an increase in SCr above 354 μmol/Lor renal replacement therapy (RRT) indication, but not the 3-fold increase in SCr increase within 7 days with SCr below 354 μmol/L.
- The patient has been informed and does not oppose the study
- The patient is insured or the beneficiary of a health insurance policy
You may not qualify if:
- The patients is under judicial protection or state guardianship
- Patient has chronic kidney disease(CKD) KDIGO stage 5
- It proves impossible to give the patient clear information
- patients living with kidney transplant
- plan dialysis for bilateral surgery nephrectomy
- patient refuse to participate and patients with no health insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Nimes
Nîmes, 30029, France
Related Publications (1)
Cardinale A, Messikh Z, Antoine V, Aglae C, Reboul P, Cariou S, Muller L, Lefrant JY, Moranne O. Specificity of severe AKI aetiology and care in the elderly. The IRACIBLE prospective cohort study. J Nephrol. 2022 Nov;35(8):2097-2108. doi: 10.1007/s40620-022-01322-z. Epub 2022 May 3.
PMID: 35503200RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2017
First Posted
June 20, 2017
Study Start
August 20, 2016
Primary Completion
December 31, 2017
Study Completion
June 15, 2018
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share